A research team led by The University of Osaka finds that elevated levels of certain immune cells in patients with systemic ...

Dr Rossby Awadzi, a GP trainee and Sickle Cell Clinical Fellow at NHS England with a passion for red cell medicine, explains how genetic counselling can empower those who may be carriers of inherited ...

RNA-seq and spatial transcriptomics showed immune cell subsets that drive kidney and lung complications in systemic sclerosis ...

"The results were intriguing," explains Masayuki Nishide, senior author. "We identified a specific subset of immune cells, the EGR1 -expressing subpopulation of CD14+ monocytes, that were clearly ...

"While most organs are thought to be shaped by static, brick-like cells, our study highlights the powerful role of dynamic, migrating cells—and how they work together to sculpt living tissue ...

Among the quiet forces reshaping U.S. warfighting readiness is a specialized group called the Drone Warfare Cell (DWC), operating within the Multi-Domain Special Operations Cell (MDSOC) at 5th ...

Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients ...

Extensive-stage small-cell lung cancer (ES-SCLC), which accounts for approximately 15% of lung cancers, is an aggressive and highly lethal disease. The current standard of care is induction therapy ...

In cells expressing CD14 (as seen with ‘professional’ antigen-presenting cells), CD14 was a co-receptor of the putative HSP70 receptor (Table 1 and Fig. 4).

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...

In CD14+ cells treated with RVL, patients with AAV exhibited significant increases in BAFF and NF-κB expression but significant decreases in APRIL and ROS expression. In patients with AAV, there was a ...